Doctor-led vulval and vaginal skin-booster assessment
Vulval Skin Boosters Assessment and Treatment
Private, doctor-led assessment for women exploring hyaluronic-acid skin boosters for vulval or vaginal dryness, tissue-quality, comfort, menopause-related or postpartum concerns. Suitability, product choice, evidence limits, risks, alternatives, treatment plan and fees are discussed before treatment.
- CQC registered Regulated and inspected
- 4.8 / 5 From 3,500+ reviews
- Assessment-led Suitability before treatment
Your first step
You do not need to know whether skin boosters are right before speaking to us
Some women are looking for targeted hydration or tissue-quality support. Others are unsure whether dryness, irritation or discomfort is hormonal, dermatological, pelvic-floor related, postpartum, menopausal or caused by something else.
That is why the consultation comes first. We listen, assess carefully, explain established care and procedural options, and only discuss vulval or vaginal skin boosters if the treatment area, selected product and available evidence are relevant to your concern.
Educational only. Not a diagnosis or medical advice. Suitability is confirmed after consultation and assessment. Results vary. This is not a cure or a standard first-line treatment for GSM. Product-specific contraindications and risks must be reviewed before treatment.
Watch patient stories, case studies and media features
The existing patient stories, case discussions and selected media features are retained here. Individual experiences do not predict suitability or the result another woman will experience.
What are vulval and vaginal skin boosters?
Skin boosters are injectable hyaluronic-acid treatments intended to place small amounts of water-binding material within selected tissues. In intimate health, they may be considered for targeted vulval or vaginal hydration and tissue-quality support after clinical assessment.
Hyaluronic acid occurs naturally in the body, but injectable products are manufactured medical or aesthetic products with different formulations, concentrations, cross-linking, intended uses and instructions. “Hyaluronic acid” does not make every product interchangeable or suitable for every part of the vulva or vagina.
A practical definition
Vulval skin boosters and vaginal skin boosters are commonly used terms for hyaluronic-acid microinjection treatments considered where the aim is hydration and tissue-quality support rather than deliberate volume augmentation or tightening. They are not hormones, lasers or a one-size-fits-all treatment for intimate symptoms.
Vaginal, vulval or vulvo-vaginal?
The vagina is the internal canal. The vulva is the external intimate area. Some concerns are mainly internal, some are mainly external, and some involve the wider vulvo-vaginal area. The treatment area should depend on symptoms, examination findings, product choice and clinical judgement.
A discreet subject
Women may ask about this treatment because of dryness, tissue fragility, discomfort, menopause-related change, postpartum change or interest in a non-hormonal procedural option. The conversation should be clinical, private and respectful — not shame-based or sales-led.
Skin booster, biorevitalisation or filler — what do the names mean?
“Skin booster” and “biorevitalisation” are broad treatment descriptions rather than one standardised product. Some hyaluronic-acid formulations are designed mainly for tissue hydration, while others provide more projection or volume. Product selection, anatomical suitability, manufacturer instructions and the agreed treatment objective all matter.
Read more: why we do not lead with a single product brand+
WHC does not promote one skin-booster brand. The doctor considers current UK regulatory requirements, product documentation, quality standards, intended use, anatomy and individual suitability before recommending any product. This keeps the discussion patient-led and prevents a brand or fixed protocol from driving the treatment decision.
Who may consider vulval or vaginal skin boosters?
Vulval or vaginal skin boosters may be discussed with selected women seeking support for vulval or vaginal tissue quality, comfort and hydration — but only after careful assessment.
Women after childbirth
Some women notice dryness or tissue change after pregnancy, birth or breastfeeding. Skin boosters may be discussed after recovery as one possible tissue-hydration option, but postpartum concerns can also involve scar tissue, pelvic-floor change, lactational hormone changes or pain and may need a different pathway.
Perimenopausal and menopausal women
Lower oestrogen levels can affect the vulva, vagina, bladder and urethra. This is often discussed under GSM. Vulval skin boosters are not a replacement for established first-line care, but may be discussed where a woman wants additional tissue-quality support after proper review.
Women exploring non-hormonal support
Some women are interested in non-hormonal options because of personal preference, previous experience, contraindications or concerns about hormones. This should be discussed medically, especially if symptoms may be better managed with established treatments.
Women wanting tissue-quality support
Others are less focused on a specific diagnosis and more concerned about tissue fragility, dryness, reduced comfort or feeling that the intimate area has changed over time. A skin booster may be considered only where the concern fits a hydration-focused treatment and no more appropriate medical, dermatological or pelvic-floor pathway is being missed.
Read more: why GSM and menopause symptoms need proper first-line care+
GSM can involve dryness, irritation, soreness, urinary symptoms, recurrent discomfort and painful intimacy. For many women, established options such as vaginal moisturisers, lubricants, vaginal oestrogen or other menopause treatments may be appropriate.
Vulval skin boosters should sit within a wider clinical conversation, not replace proper diagnosis or established care where that care is suitable.
Concerns we assess before considering treatment
Women enquiring about vulval or vaginal skin boosters often describe one or more of the following concerns.
These symptoms do not automatically mean skin boosters are suitable. Similar symptoms can be caused by hormonal change, skin conditions, infection, inflammation, pelvic floor dysfunction, medication, pain conditions or other medical issues.
Who may not be suitable?
Vulval skin boosters may not be appropriate, or may need to be delayed, if there is:
Why assessment matters
Dryness, pain, urinary symptoms, irritation or tissue changes can have different causes. A hyaluronic-acid injection should not be used to bypass diagnosis, menopause care, dermatology review or pelvic-floor assessment where those are needed.
Realistic expectations
Skin boosters may support tissue quality pathways in selected women, but they are not a cure for GSM, atrophy, pain, dryness, sexual dysfunction or urinary symptoms. Response varies and some women may not notice meaningful change.
Risks and limitations
As with any injectable treatment, risks and limitations must be discussed before treatment.
Read more: why “non-hormonal” does not mean “better for everyone”+
Some women prefer non-hormonal options, and that preference should be respected. However, if symptoms are caused by oestrogen deficiency or GSM, established first-line treatments may be more appropriate, better evidenced or more cost-effective. The right plan depends on the woman, the symptoms and the clinical findings.
Why women ask about skin boosters
Most women are not looking for hype. They want to understand why their tissue feels different, whether it is normal, whether treatment is appropriate, and what options are realistic.
Functional and comfort reasons
Women may ask because dryness, sensitivity, irritation, soreness, tissue fragility or discomfort has affected daily comfort, exercise, clothing, intimacy or confidence.
Life-stage reasons
Menopause, childbirth, breastfeeding, ageing, hormonal shifts and some medical treatments can change vulval and vaginal tissue. The treatment discussion should be shaped by the cause.
Emotional reasons
Some women feel embarrassed, dismissed or unsure how to raise intimate symptoms. A respectful consultation can help clarify what is happening and what may genuinely help.
Hydration and tissue quality
Skin boosters are being explored for tissue quality and hydration support, especially where women describe dryness, fragility or reduced comfort.
Water-binding rationale
Hyaluronic acid binds water. The treatment rationale is therefore hydration and tissue-quality support; the degree and duration of any response depend on the formulation, treatment area and individual tissue.
Confidence through clarity
Sometimes the most important step is understanding the cause of symptoms and knowing which options are sensible, rather than assuming one procedure is the answer.
Balanced, evidence-aware care
We use “may support” language because findings from specific products and study groups cannot be generalised to every skin booster, every anatomical area or every woman. That honesty is part of responsible, doctor-led care.
What women may be hoping for
Women may be looking for improved comfort, better hydration, stronger tissue resilience, less irritation, more confidence or additional support alongside menopause care. These are goals for discussion, not promised outcomes.
Results vary from person to person. Suitability is always confirmed after consultation and assessment.
How vulval and vaginal skin-booster treatment works
The injection appointment may be relatively short, but the clinical decision should be careful. The aim is to match treatment to symptoms, anatomy, medical context and realistic goals.
1. Doctor consultation
We review your symptoms, medical history, menopause or postpartum context, current treatments, medications, allergies, expectations and whether first-line care has been considered.
2. Assessment and planning
The plan may consider external vulval skin, the labia majora, labia minora, vestibule or introitus, and selected vaginal tissues. The final area, formulation, technique and number of sessions depend on symptoms, examination, product documentation and clinical judgement.
3. Treatment session
Local anaesthetic or other comfort measures may be used where appropriate. The area is cleaned and small amounts of the selected hyaluronic-acid product are placed using the planned injection technique. The appointment length depends on the treatment area and plan.
4. Aftercare and review
You receive written aftercare, what to expect, what to avoid temporarily, when to contact the clinic, and whether further sessions may be appropriate.
How hyaluronic-acid skin boosters may support tissue quality
Hyaluronic acid is a glycosaminoglycan found naturally in connective tissues and extracellular matrix. Injectable formulations can bind water and alter local hydration and tissue behaviour. Formulation, cross-linking, concentration, injection depth and anatomical area affect how a product behaves, so findings from one product cannot be assumed for another.
Water binding
Hyaluronic acid attracts and retains water. This is the clearest rationale for describing a skin booster as a hydration-focused treatment.
Hydration support
The selected product is placed within clinically chosen tissues rather than applied only to the surface. This does not mean that every cause of dryness will respond to injection.
Formulation matters
Cross-linked and non-cross-linked products, concentrations and rheological properties differ. The doctor must match product characteristics and manufacturer information to the intended area and objective.
Gradual response
Some women may notice hydration or comfort changes after treatment, but response and timing vary. The aim is not guaranteed volume, tightening, sexual improvement or permanent tissue regeneration.
Plain-English way to think about it
A vulval skin booster places a water-binding injectable within selected tissue to pursue a hydration or tissue-quality objective. It should not be presented as a cure, a replacement for missing hormones, a treatment for every vulval symptom or a way to “reverse ageing”.
How do vulval and vaginal skin boosters compare with other treatments?
Women often hear several treatment names at once: skin boosters, O-Shot, PRP, G-Shot, filler, vaginal laser, exosomes and vaginal rejuvenation. They are not the same. The best option depends on symptoms, anatomy, medical history, evidence, expectations and suitability.
Skin boosters vs O-Shot / PRP
PRP uses platelet-rich plasma prepared from the woman’s own blood. Skin boosters use a manufactured hyaluronic-acid product. The source, preparation, evidence, contraindications and treatment objectives differ. Read about O-Shot-style intimate and vaginal PRP.
Skin boosters vs G-Shot / filler
Both may use hyaluronic acid, but G-Shot-style or intimate filler is planned for focal projection or volume, while a skin booster is planned mainly for hydration and tissue quality. Product properties, placement and objectives are different. Compare G-Shot and intimate vaginal filler.
Skin boosters vs vaginal laser / RF
Laser and radiofrequency use energy rather than an injectable material. Their proposed mechanisms, evidence, risks, recovery and suitability differ, and they are not interchangeable with hyaluronic-acid injections.
Skin boosters vs polynucleotides or exosomes
Polynucleotides and exosome-based approaches use different materials and have different evidence and regulatory considerations. They should not be grouped together simply because each may be marketed for “regeneration”. Compare intimate and vaginal polynucleotides or intimate and vaginal exosomes.
Where vaginal rejuvenation fits
“Vaginal rejuvenation” is a broad consumer term covering different goals and procedures. Vulval or vaginal skin boosters are one injectable option within that wider discussion, not a replacement for diagnosis or established care.
Read about vaginal rejuvenationRecovery and aftercare
Most women can return to normal gentle activities soon after treatment, but mild swelling, sensitivity, bruising, redness or small injection-site bumps can occur.
You will receive written aftercare advice, including what is expected and when to contact the clinic.
You may be advised to avoid intercourse, tampons, swimming, saunas, hot baths, harsh cleansers and strenuous exercise for a short period.
Exact aftercare depends on the treatment area, product, protocol and your individual clinical plan.
Results and maintenance
What to expect over time
Response varies. Planning should be individual rather than one-size-fits-all.
When might changes be noticed?
Published product-specific studies have reported symptom changes from around four weeks in selected postmenopausal groups, but this cannot predict an individual result or be generalised to every product and indication. Some women may notice little or no meaningful change.
How many sessions are needed?
Published protocols vary from a single treatment to a course. WHC does not use one fixed schedule: the number and interval of sessions depend on assessment, selected product, treatment area, response and clinical judgement.
Is maintenance needed?
Effects should not be presented as permanent. Review, maintenance or repeat treatment may be discussed only if there has been benefit, the woman remains suitable and the selected product’s guidance supports the proposed plan.
Vulval and vaginal skin boosters before and after
These before-and-after images are artistic impressions for illustration only. They are not clinical photographs and do not show a guaranteed anatomical, vaginal, tissue-quality, hydration, comfort or sensory response. Outcomes vary according to the concern, product, treatment area, tissue quality, hormonal background, treatment plan and individual response.
Request a confidential consultationIllustrative before & after
The slider is an artistic representation, not a clinical photograph or promise of outcome. Suitability, evidence limits, risks and realistic expectations are discussed during consultation.
Doctor-led care at The Women’s Health Clinic
Vulval and vaginal hyaluronic-acid injections require clinical judgement, not just injection technique. We keep the discussion private, explain the product, evidence and limitations, and help women understand whether skin boosters, established care, another treatment or no procedure is the most appropriate direction.
Women-friendly, respectful care
We understand that many women feel uncertain, embarrassed or dismissed when raising intimate concerns. The conversation should feel calm, discreet and medically grounded.
Clear and realistic explanations
We explain what skin boosters are designed to support, what they cannot promise, where evidence is limited, and when another pathway may be better.
Why women choose WHC
Doctor-led, women-centred, private, evidence-aware care with clarity rather than pressure.
Part of a broader vaginal wellness pathway
Vulval skin boosters may sit alongside broader vaginal wellness, vaginal rejuvenation, menopause care, pelvic floor support or conservative symptom management, depending on the clinical picture.
Guide pricing
Vulval skin boosters
We advise a doctor face-to-face consultation before treatment so that symptoms, suitability, expectations, alternatives and the treatment plan can be properly reviewed.
Doctor face-to-face consultation
Recommended before treatment so the cause of symptoms, suitability, risks and alternatives can be properly assessed.
Doctor consultation
Session or course pricing
Treatment pricing depends on product, number of sessions, area treated and clinical plan. Please check the pricing page for current treatment fees.
Current fees may change
Alternatives may be advised
Some women may be better suited to menopause care, moisturisers, lubricants, pelvic floor support, vaginal rejuvenation, PRP or another pathway.
Plan confirmed after review
Why consultation comes before treatment pricing
The correct plan depends on whether skin boosters are suitable at all, whether another treatment would be more appropriate, and whether a course or alternative pathway is needed.
What treatment fees depend on
Treatment fees may vary according to the product used, number of sessions, area treated, treatment plan and any combination pathway agreed after consultation.
Check latest pricing
Please use the pricing page for the latest published treatment fees. If pricing is updated, that page should be treated as the source of truth.
Experience
How women often want the experience to feel
Women considering vulval or vaginal skin boosters often want privacy, honest explanations and a clinician who will not exaggerate outcomes.
We avoid claiming that skin boosters reverse menopause, cure dryness, fix painful sex or restore intimate health. Instead, we explain the treatment carefully, discuss suitability and evidence, and help women make an informed decision.
Feeling listened to
A good treatment journey begins with understanding the concern, not rushing to the procedure.
Clear explanations
We explain treatment mechanism, risks, limitations, evidence, costs and alternatives in plain language.
No pressure
If vulval or vaginal skin boosters are not suitable, we will explain why and discuss a more appropriate direction.
Patient journey
A typical consultation-led pathway
Every woman’s story is different, but many follow a similar route from uncertainty to clarity.
1. She notices a change
It may be dryness, discomfort, irritation, tissue fragility, menopause-related change or postpartum change.
2. She researches options
She may find skin boosters, PRP, laser, filler, exosomes and vaginal rejuvenation, and feel unsure what is appropriate.
3. She books consultation
We advise a face-to-face doctor consultation so the concern can be properly understood before treatment is considered.
4. She has a proper review
We assess symptoms, anatomy, menopause context, postpartum history, first-line options, risks and expectations.
5. She receives a tailored plan
That may include skin boosters, first-line care, menopause support, PRP, vaginal rejuvenation, pelvic floor support or no procedure.
Frequently Asked Questions
Clear answers to common questions about vulval and vaginal skin boosters, evidence, suitability, aftercare and comparison with other treatments.
Vulval and vaginal skin boosters are injectable hyaluronic-acid treatments considered for targeted hydration and tissue-quality support. “Skin booster” is a broad treatment description, so the exact formulation, intended use and anatomical area must be reviewed before treatment.
Hyaluronic acid binds water within tissues. A selected injectable formulation may therefore be used with the aim of supporting local hydration and tissue quality. Product properties and placement affect how it behaves, and the treatment cannot correct every cause of vulval or vaginal dryness.
No injectable procedure is risk-free. Expected reactions can include pain, redness, swelling, bruising, tenderness and temporary bumps. Infection, inflammatory or allergic reactions, lumps or irregularity, and rare vascular injury or tissue damage must also be considered. Risk depends on the product, anatomy, technique and patient factors.
They may be discussed with selected women seeking tissue quality, hydration or comfort support, especially in menopause-related, postpartum or age-related intimate tissue changes. Suitability is confirmed only after consultation and assessment.
This treatment is not suitable for everyone. It may need to be avoided or delayed during pregnancy or breastfeeding, with active infection or uncontrolled inflammation, unexplained bleeding or pain, a lump, ulcer or suspicious skin change, relevant allergy, bleeding or healing concerns, a product-specific contraindication or unrealistic expectations.
They may be discussed after menopause in selected women, but they are not a replacement for established GSM care. Vaginal moisturisers, lubricants, vaginal oestrogen or other menopause treatments may be more appropriate depending on symptoms and medical history.
Randomised and follow-up studies of particular injectable hyaluronic-acid formulations have reported improvement in selected postmenopausal women with vulvovaginal atrophy symptoms. These results do not establish that every skin booster treats every cause of dryness. Diagnosis and established options still need to be considered.
Local comfort measures may be used. Some women experience stinging, pressure or sensitivity during or after treatment. We do not describe injectable intimate treatments as painless.
The treatment involves consultation, suitability assessment, consent, cleaning the area, local comfort measures if appropriate, and careful placement of the skin-booster injectable in the planned vulval and/or vaginal area.
Published protocols vary from a single session to a course. WHC does not apply one schedule to every woman. The number and spacing of sessions depend on the selected product, treatment area, symptoms, clinical plan and response.
Duration varies. A 52-week follow-up study reported sustained changes after one specific cross-linked hyaluronic-acid protocol in selected postmenopausal women, but that result cannot be applied to every product, anatomical area or patient. Effects are not permanent or guaranteed.
Recovery is usually short, but mild redness, swelling, bruising, small bumps, tenderness or sensitivity can occur. You may be advised to avoid intercourse, tampons, swimming, saunas, hot baths or vigorous exercise for a short period.
Sometimes, but only as an assessment-led plan. Skin boosters may be considered alongside established menopause care, PRP, laser, polynucleotides or another treatment, either within a staged pathway or separately. Combination treatment is not automatically better and should not be undertaken simply to intensify the procedure.
PRP uses platelet-rich plasma prepared from your own blood. Skin boosters use a manufactured hyaluronic-acid product. The materials, preparation, evidence, contraindications and treatment objectives are different.
Both may use hyaluronic acid, but G-Shot-style or intimate filler treatment is usually planned for focal projection or volume. A skin booster is planned mainly for hydration and tissue-quality support. Product characteristics, placement and objectives differ.
Vaginal laser and radiofrequency use energy; skin boosters place a hyaluronic-acid material into selected tissue. Their mechanisms, evidence, risks, recovery and suitability differ. None should be presented as universally better.
No. Products differ in formulation, concentration, cross-linking, rheology, intended use and manufacturer instructions. A product used for facial skin quality cannot automatically be assumed suitable for vulval or vaginal tissue.
Evidence is emerging and product-specific. A 2025 multicentre randomised placebo-controlled study assessed one cross-linked hyaluronic-acid gel in postmenopausal vulvovaginal atrophy, with later follow-up reporting changes to 52 weeks. Other studies are small or use different products and protocols. Skin boosters remain outside standard first-line NICE care for GSM.
We advise a doctor face-to-face consultation at £150 before treatment. Treatment/session fees should be checked on the current WHC pricing page because pricing may vary by product, area treated, number of sessions and plan.
Vulval skin boosters are not a standard NHS treatment for menopause-related intimate symptoms. Women with vaginal dryness, pain, bleeding, urinary symptoms or vulval changes should seek appropriate medical assessment and discuss established treatment options.
WHC does not promote or commit to one brand. The doctor selects from suitable products available for UK practice after reviewing current product documentation, quality and regulatory requirements, intended use, anatomical area and individual suitability. You should be told which product is proposed before consent.
They may be discussed after recovery in selected women, but postpartum concerns can involve pelvic-floor change, scar tissue, breastfeeding-related hormone change, infection or pain. Treatment is not undertaken during pregnancy or breastfeeding, and assessment is needed before any later procedure is considered.
Do not stop prescribed HRT or vaginal hormone treatment without medical advice. Your current menopause treatment, vaginal oestrogen, moisturisers, lubricants and other medications should be discussed during consultation.
Your next steps
1. Book a doctor face-to-face consultation
2. Talk through your symptoms and concerns
3. Review first-line care and alternative options
4. Understand whether skin boosters are suitable
5. Move forward only if it feels right for you
If something has changed, you do not need to have all the answers before getting in touch. You simply need a place to ask questions openly and understand your options clearly.
What does the evidence say?
The most relevant evidence concerns injectable hyaluronic acid for vulvovaginal atrophy or selected vulval conditions. It does not validate every treatment marketed as a “skin booster”. Study formulation, participant group, injection sites, comparator and follow-up must be considered before applying a result to clinical practice.
Randomised evidence exists
A 2025 multicentre randomised placebo-controlled study evaluated one cross-linked hyaluronic-acid gel in postmenopausal women with moderate-to-severe vulvovaginal atrophy symptoms. This is stronger than an uncontrolled case series, but it remains evidence for that studied formulation and population.
Follow-up is product-specific
A later 52-week follow-up reported sustained symptom and sexual-function score changes after the same protocol. A separate 20-participant study compared non-cross-linked hyaluronic acid with PRP. These findings are encouraging but do not establish a class-wide duration or universal benefit.
Not first-line GSM care
NICE menopause guidance discusses vaginal oestrogen and non-hormonal moisturisers and lubricants for genitourinary symptoms. Injectable skin boosters are not listed as standard first-line GSM care, so established options should be discussed where appropriate.
Our position
WHC does not promote one brand or apply one protocol to every woman. Before treatment, the doctor considers current UK requirements, manufacturer documentation, product traceability, anatomical suitability, available evidence, alternatives and the individual treatment objective. The exact product proposed should be explained before consent.
Research and guidance used for this page+
- Lamiraud et al., 2025 — 12-week multicentre randomised placebo-controlled study of a specific cross-linked hyaluronic-acid injection for postmenopausal vulvovaginal atrophy.
- Bensmail et al., 2025 — 52-week follow-up of the same treatment pathway.
- Ragy et al., 2025 — small randomised comparison of non-cross-linked hyaluronic acid and PRP in 20 postmenopausal participants.
- Buzzaccarini et al., 2021 — review of vulval and vaginal hyaluronic-acid administration that called for well-designed randomised trials.
- NICE NG23: Menopause — guideline-based management of genitourinary symptoms.
- MHRA information on dermal fillers — UK medical-device status, adverse-incident interpretation and Yellow Card reporting.
Responsible wording matters
Treatments involving intimate anatomy, needles, body confidence, menopause symptoms or sexual comfort should not be advertised as simple, risk-free, painless, guaranteed or emotionally transformative.
We avoid saying
We prefer saying
This wording is not just about compliance. It is about trust. A woman considering vulval or vaginal skin boosters deserves an honest explanation of what the treatment is designed to do, what it cannot promise, what the risks are, and when another pathway may be more appropriate.
Related Intimate Health Guides
Read expert women’s health articles
Explore our expert medical articles covering women’s health, menopause, intimate health, gynaecology, regenerative wellness and preventative care. These resources are written to help patients understand their options before booking a consultation.
Dr. Hany Mostafa
Specialist in obstetrics & gynaecology Dr. Hany Mostafa is a Consultant Obstetrician and Gynaecologist specializing in reproductive medicine…
Read MoreStill not sure where to start?
Browse the wider treatment pages or book a free consultation.
Browse our women’s health FAQs
Find clear answers to common questions about consultations, treatments, symptoms, preparation, aftercare, pricing and what to expect when visiting The Women’s Health Clinic. Use the FAQ bubbles below to continue exploring.
